Roche Pharma (Schweiz) AG - Rozlytrek 200 mg, Hartkapseln | | 67280 | | 02 | | Rozlytrek 200 mg | | Hartkapseln | | L01EX14 | | Entrectinib | | 05.11.2020 | | |
| Composition | entrectinibum 200 mg, lactosum 130 mg, cellulosum microcristallinum, acidum tartaricum, hypromellosum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: hypromellosum, E 171, E 110 0.5543 mg, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 132, pro capsula. | Packungsbestandteile | | Capsules | | | Active Agent | Dose |
---|
Entrectinibum | 200 mg |
| BAG: Active Agent | Dose |
---|
Entrectinibum | 200 mg |
| | Inactive agents | Dose | additional_information |
---|
Tartaric Acid | | | Ammoniae Solutio Concentrata | | | Cellulosum Microcristallinum | | | Crospovidonum | | | E 110 | 0.5543 mg | color. | E 132 | | color. | E 171 | | color. | Hypromellosum | | Kapselhülle | Lacca | | Drucktinte | Lactosum | 130 mg | | Magnesii Stearas | | | Pro Capsula | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
002 | 90 | 4906.67 | 5342.05 | A | SL | Yes |
|
|